Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2026 08:00 ET | Source: Omniscient Neurotechnology

Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology

Omniscient (o8t®) secures $27.2M Series D funding to scale its AI-powered Quicktome® brain mapping platform and accelerate personalized brain care globally
January 14, 2026 11:30 ET | Source: Omniscient Neurotechnology

Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping

Omniscient secures new AMA CPT® code for connectomic analysis, validating Quicktome’s clinical utility in brain care and advancing reimbursement.
July 24, 2025 11:46 ET | Source: Omniscient Neurotechnology

Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics

Omniscient and The Jacobs Institute launch Connectomics Innovation Program to advance stroke recovery and neurologic care with AI-enabled software.
June 11, 2024 11:00 ET | Source: Omniscient Neurotechnology

AI Brain Health Leader Omniscient Closes Series C Funding Round

Omniscient secures Series C funding to expand Quicktome® platform, advancing connectomics for improved brain health diagnostics and treatments.
June 02, 2023 10:00 ET | Source: Omniscient Neurotechnology

Omniscient Announces FDA-Clearance of New MRI-based Functional Brain Analysis Technology

FDA-cleared AI brain-mapping software, Quicktome FC (Functional Connectome), maps functional connectivity of a patient’s unique networks - involved in crucial functions such as movement, language, and...
October 24, 2022 08:30 ET | Source: Omniscient Neurotechnology

Omniscient Neurotechnology Appoints Two New Members to Its Board of Directors

SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara...